C

Citius Oncology Inc
D

CTOR

2.64000
USD
1.09
(70.32%)
قبل الجلسة
حجم التداول
692
الربح لكل سهم
-0
العائد الربحي
-
P/E
-6
حجم السوق
188,898,341
المقالات

العنوان: Citius Oncology Inc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.